CoSign Electronic Signatures delivered with DataLabs Site Manager 2.0


Applied Clinical Trials

Applied Clinical TrialsApplied Clinical Trials-06-19-2006
Volume 0
Issue 0

CoSign electronic signature reduces the time and cost of clinical trials, helping sponsors and CROs comply with the FDA's 21 CFR Part 11 and GxP regulations.

PHILADELPHIA-June 19, 2006-Algorithmic Research (ARX), a leading worldwide provider of electronic signatures and data security solutions, announced from the Drug Information Association (DIA) 42nd Annual Conference an agreement to integrate its CoSign electronic signature solution with DataLabs' Site Manager 2.0 collaboration software.

This integrated solution enables sponsors and CROS to electronically sign documents, forms and agreements using standard electronic signatures, which reduces the time and cost to clinical trials while complying with the FDA's 21 CFR Part 11 and GxP regulations.

DataLabs will be at booth #1829 at the DIA Annual Conference

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.